Clinical Trial Update: NIRTRAKS Post-Market Study (NIRTRAKS) [NA]

View source ↗

Summary

Completed post-market study of NIRTRAKS in de novo stenotic lesions of native coronary arteries with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NIRTRAKS

Snippet

Sponsor: Medinol Ltd. | Conditions: de Novo Stenotic Lesions in Native Coronary Arteries | NA | Status: COMPLETED | Results posted: 2023-10-04